FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

GETLIN LAWRENCE W 		2. Issuer Name and Ticker or Trading Symbol

ProUroCare Medical Inc. [ PUMD ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

2690 PHEASANT RD 		3. Date of Earliest Transaction (MM/DD/YYYY)

12/28/2012
(Street)

EXCELSIOR, MN 55331
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, $0.00001 par value   12/28/2012     A (4)    8594   A $0.64   59772   D    
Common Stock, $0.00001 par value   12/28/2012     M (3)    5243   A $1.10   65015   D    
Common Stock, $0.00001 par value   1/2/2013     A (5)    20000   A $0.64   85015   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options   $0.92                      (1) 6/27/2018   Common Stock, $0.00001 par value   2265     2265   D    
Convertible notes   $1.30                      (1) 9/15/2013   Common Stock, $0.00001 par value   19231     $25000   D    
Stock Options   $0.87                      (1) 8/9/2018   Common stock, $0.00001 par value   28736     28736   D    
Stock Options   $0.60                      (2) 8/9/2019   Common stock, $0.00001 par value   25000     25000   D    
Convertible Note   $1.10   12/28/2012     M   (3)       5243      (3) 12/28/2012   Common stock, $0.00001 par value   5243   $1   $0   D    

Explanation of Responses:
( 1)  Currently exercisable.
( 2)  Annual option award pursuant to the Issuer's compensation policy for Directors upon their re-election to the Board of Directors. The seven-year options vest ratably over 12 months.
( 3)  On December 28, 2012, the reporting person converted a convertible promissory note in the principal amount of $5,200, along with accrued interest thereon of $568, into common shares pursuant to the terms of the note. The transaction was approved by the Company's Board of Directors and is exempt under section 16b-3(d).
( 4)  Shares issued to directors in payment of directors' fees earned during the period from July 1, 2012 and December 31, 2012, in lieu of cash. The Issuer's Board of Directors specifically approved the transaction as exempt from the requirements of Section 16b as provided by Rule 16b-3(d).
( 5)  On January 2, 2013, the issuer issued 20,000 shares to the reporting person in lieu of cash for $12,800 of consulting fees due to the reporting person. The issuer's Board of Directors specifically approved the transaction as exempt from the requirements of Section 16b as provided by Rules 16b-3(d).

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
GETLIN LAWRENCE W
2690 PHEASANT RD
EXCELSIOR, MN 55331 		X



Signatures
Richard B. Thon by power of attorney 1/2/2013
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
ProUroCare Medical (CE) (USOTC:PUMD)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas ProUroCare Medical (CE).
ProUroCare Medical (CE) (USOTC:PUMD)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas ProUroCare Medical (CE).